Vident Advisory LLC purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 14,405 shares of the health services provider's stock, valued at approximately $1,075,000.
A number of other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the last quarter. V Square Quantitative Management LLC raised its stake in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new stake in Maximus in the fourth quarter valued at approximately $54,000. IFP Advisors Inc lifted its position in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in shares of Maximus by 109.2% during the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock worth $61,000 after acquiring an additional 428 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Performance
Shares of MMS stock traded up $2.21 during midday trading on Tuesday, hitting $74.61. 395,575 shares of the company were exchanged, compared to its average volume of 561,827. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The firm has a market capitalization of $4.20 billion, a P/E ratio of 16.05 and a beta of 0.61. The firm's 50 day moving average price is $69.44 and its two-hundred day moving average price is $71.91. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the business posted $1.57 earnings per share. The business's revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.61%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is 23.86%.
Insider Transactions at Maximus
In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Read Our Latest Research Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
